Compounded Infliximab for Intravenous Infusion
Berkshire Healthcare NHS Foundation Trust · United Kingdom
Key facts
- Estimated value
- £5,000,000
- Closing date
- 02 Sep 2020
- Contract starts
- 01 Jan 2021
- Contract ends
- 31 Dec 2022
- Procedure
- Restricted procedure (above threshold)
- Buyer type
- Health
Description
Provision of Compounded Infliximab to: Trusts who are members of:
Thames Valley & Wessex Pharmacy Procurement Service NHS Commercial Solutions East of England NHS Collaborative Procurement Hub NHS London Procurement Partnership
Full details of all Trusts involved can be found in the SSQ and ITT documents. These can be obtained from:
https://www.nhssourcing.co.uk/bhft/web/login.shtml
The requirement will be split into 5 Lots as follows: Lot 1 - Inflectra, Lot 2 - Remicade, Lot 3 - Remsima, Lot 4 - Flixabi, and Lot 5 - Zessly.
This will be a ranked framework with a maximum of 5 suppliers per lot.
The duration will be 2 years with 2 options for 12 month extensions (maximum duration 4 years).
Additional information: TO DOWNLOAD A SSQ Register your company on the eSourcing portal (this is only required once): - browse to the ESourcing Portal: https://www.nhssourcing.co.uk/bhft/web/login.shtml and click the link to register, - accept the terms and conditions and click 'continue', - enter your correct business and user details, - note the username you chose and click 'save'- when complete, - you will shortly receive an email with your unique password (please keep secure). Login to the portal with the username/password: - click the 'PQQ/ITTs open to all suppliers' link (these are Pre-Qualification Questionnaires or tenders open to any registered suppliers), - click on the relevant PQQ/ITT to access the content, - click the 'Express Interest' button in the 'Actions' box on the left-hand side of the page. This will move the PQQ into your My PQQ/My ITTs page (this is a secure area reserved for your projects only), - you can now access any of the attachments by clicking the 'Settings and Buyer Attachment' in the 'Actions' box.
Categories (CPV)
- 33600000 Pharmaceutical products
Similar open tenders
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202633 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
National Generic Pharmaceuticals – Project Revive
Location: LondonBuyer: NHS England
Open tenderCloses 30 Nov, 202625 daysValue £6.86mSource Find a TenderNational Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202625 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20264 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202611 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.